EHD1 Recombinant Antibody
Applications
Reactivity
| Overview | |
| Catalog # | bsm-62011r |
| Product Name | EHD1 Recombinant Antibody |
| Applications |
WB
FCM
IHC-P
IHC-F
IF(IHC-P)
IP
|
| Reactivity | Human, Mouse, Rat |
| Specifications | |
| Conjugation | Unconjugated |
| Host | Rabbit |
| Source | KLH conjugated synthetic peptide derived from human EHD1 |
| Clonality | Recombinant |
| Isotype | IgG |
| Concentration | Lot dependent |
| Purification | Purified by Protein A. |
| Storage Buffer | 0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol |
| Storage Condition | Shipped at 4C. Store at -20C for one year. Avoid repeated freeze/thaw cycles. |
| Target | |
| Gene ID | 10938 |
| Swiss Prot | Q9H4M9 |
| Subcellular location | Cell membrane |
| Synonyms | EHD1; H PAST; hPAST1; PAST; PAST homolog 1; PAST1; Testilin. |
| Background | ATP- and membrane-binding protein that controls membrane reorganization/tubulation upon ATP hydrolysis. In vitro causes vesiculation of endocytic membranes.Acts in early endocytic membrane fusion and membrane trafficking of recycling endosomes.Recruited to endosomal membranes upon nerve growth factor stimulation, indirectly regulates neurite outgrowth. |
| Application Dilution | |
| WB | 1:500-2000 |
| FCM | FCM1:50-100 |
| IHC-P | IHC-P1:100-200 |
| IHC-F | IHC-F1:100-200 |
| IF(IHC-P) | IFIHC-P1:50-200 |
| IP | IP1:20-50 |
Frequently asked questions
Which applications is EHD1 Recombinant Antibody (bsm-62011R) validated for, and at what dilution?
bsm-62011R is validated for WB(WB) (1:500-2000); FCM(FCM) (1:50-100); IHC-P(IHC-P) (1:100-200); IHC-F(IHC-F) (1:100-200); IF(IHC-P)(IF(IHC-P)) (1:50-200); IP(IP) (1:20-50). These are recommended starting dilutions; optimal dilutions should be determined by the end user.
Which species does EHD1 Recombinant Antibody (bsm-62011R) react with?
Tested reactivity: Human, Mouse, Rat.
How should bsm-62011R be stored?
Shipped at 4C. Store at -20C for one year. Avoid repeated freeze/thaw cycles. Storage buffer: 0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol
What immunogen was used to raise EHD1 Recombinant Antibody (bsm-62011R)?
KLH conjugated synthetic peptide derived from human EHD1
